[PDF][PDF] Structural and functional basis of mammalian microRNA biogenesis by Dicer
D Zapletal, E Taborska, J Pasulka, R Malik, K Kubicek… - Molecular Cell, 2022 - cell.com
MicroRNA (miRNA) and RNA interference (RNAi) pathways rely on small RNAs produced
by Dicer endonucleases. Mammalian Dicer primarily supports the essential gene-regulating …
by Dicer endonucleases. Mammalian Dicer primarily supports the essential gene-regulating …
Long terminal repeats power evolution of genes and gene expression programs in mammalian oocytes and zygotes
…, S Ganesh, R Karlic, R Malik, J Pasulka… - Genome …, 2017 - genome.cshlp.org
Retrotransposons are “copy-and-paste” insertional mutagens that substantially contribute to
mammalian genome content. Retrotransposons often carry long terminal repeats (LTRs) for …
mammalian genome content. Retrotransposons often carry long terminal repeats (LTRs) for …
Serine phosphorylation and proline isomerization in RNAP II CTD control recruitment of Nrd1
K Kubicek, H Cerna, P Holub, J Pasulka… - Genes & …, 2012 - genesdev.cshlp.org
Recruitment of appropriate RNA processing factors to the site of transcription is controlled
by post-translational modifications of the C-terminal domain (CTD) of RNA polymerase II (…
by post-translational modifications of the C-terminal domain (CTD) of RNA polymerase II (…
TUT‐DIS3L2 is a mammalian surveillance pathway for aberrant structured non‐coding RNAs
D Ustianenko, J Pasulka, Z Feketova, L Bednarik… - The EMBO …, 2016 - embopress.org
Uridylation of various cellular RNA species at the 3′ end has been generally linked to RNA
degradation. In mammals, uridylated pre‐let‐7 miRNAs and mRNAs are targeted by the 3′ …
degradation. In mammals, uridylated pre‐let‐7 miRNAs and mRNAs are targeted by the 3′ …
[HTML][HTML] Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
…, M Kovar, M Reinis, R Mikyskova, J Pasulka… - Cell Death & …, 2023 - nature.com
While type I interferon (IFN) is best known for its key role against viral infection, accumulating
preclinical and clinical data indicate that robust type I IFN production in the tumor …
preclinical and clinical data indicate that robust type I IFN production in the tumor …
An autologous dendritic cell vaccine promotes anticancer immunity in patients with ovarian cancer with low mutational burden and cold tumors
…, M Hensler, L Kasikova, T Lanickova, J Pasulka… - Clinical Cancer …, 2022 - AACR
Purpose: The successful implementation of immune checkpoint inhibitors (ICI) in the clinical
management of various solid tumors has raised considerable expectations for patients with …
management of various solid tumors has raised considerable expectations for patients with …
[HTML][HTML] Formation of spermatogonia and fertile oocytes in golden hamsters requires piRNAs
PIWI-interacting RNAs (piRNAs) support the germline by suppressing retrotransposons.
Studies of the pathway in mice have strongly shaped the view that mammalian piRNAs are …
Studies of the pathway in mice have strongly shaped the view that mammalian piRNAs are …
Can we execute stable microsecond-scale atomistic simulations of protein–RNA complexes?
We report over 30 μs of unrestrained molecular dynamics simulations of six protein–RNA
complexes in explicit solvent. We utilize the AMBER ff99bsc0χ OL3 RNA force field combined …
complexes in explicit solvent. We utilize the AMBER ff99bsc0χ OL3 RNA force field combined …
RBM7 subunit of the NEXT complex binds U-rich sequences and targets 3′-end extended forms of snRNAs
…, D Potesil, M Bartosovic, J Pasulka… - Nucleic Acids …, 2015 - academic.oup.com
The Nuclear Exosome Targeting (NEXT) complex is a key cofactor of the mammalian nuclear
exosome in the removal of Promoter Upstream Transcripts (PROMPTs) and potentially …
exosome in the removal of Promoter Upstream Transcripts (PROMPTs) and potentially …
Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines
…, J Rakova, L Kasikova, T Lanickova, J Pasulka… - …, 2022 - Taylor & Francis
Dendritic cells (DCs) have received considerable attention as potential targets for the
development of novel cancer immunotherapies. However, the clinical efficacy of DC-based …
development of novel cancer immunotherapies. However, the clinical efficacy of DC-based …